Skip to Content
Søg Menu
Velkommen til lungecancer

Få de seneste artikler og MEDtalks om lungecancer

Seneste nyt om lungecancer

Lung Cancer Insights: What’s New in the Field – January Update

  • / Jan Andreasen / Amanda Feldballe Bernholm

Milla Katajisto

ELCC 2026: Digital Tool for ECOG Assessment in Lung Cancer

/ Milla Katajisto
ELCC26Lungecancer Play the Video
Cecilie Mondrup Jacobsen

ELCC 2026: Blood-Based ML for Lung Cancer Prediction

/ Cecilie Mondrup Jacobsen
ELCC26Lungecancer Play the Video
Fred Hirsch

ELCC 2026: AI-Assisted PD-L1 Assessment in Lung Cancer

/ Fred Hirsch
ELCC26Lungecancer Play the Video

Lung Cancer Highlights

Danish and Nordic Lung Cancer Insights – December Update

/ Jan Andreasen / Amanda Feldballe Bernholm
lung cancer-highlightsLungecancer

Danish and Nordic Lung Cancer Insights – October Update

/ Jan Andreasen / Amanda Feldballe Bernholm
lung cancer-highlightsLungecancer

Lung Cancer Insights: What’s New in the Field – October Update

/ Jan Andreasen / Amanda Feldballe Bernholm
lung cancer-highlightsLungecancer

Lung Cancer Insights: What’s New in the Field

/ Jan Andreasen / Amanda Feldballe Bernholm
lung cancer-highlightsLungecancer

MEDtalks

Martin Reck

ELCC 2026: Pembrolizumab + Chemo Improves EFS in Early-Stage NSCLC

/ Martin Reck
ELCC26Lungecancer Play the Video
Fred Hirsch

ELCC 2026: Cemiplimab + Chemo Benefits STK11-Mutant Non-Squamous NSCLC

/ Fred Hirsch
ELCC26Lungecancer Play the Video
Bjørn H Grønberg

ELCC 2026: Key Trial Updates in Lung Cancer

/ Bjørn Henning Grønberg
ELCC26Lungecancer Play the Video
Jonathan Lee

ELCC 2026: Tumor-Agnostic ctDNA Methylation for Recurrence Prediction

/ Jonathan Lee
ELCC26Lungecancer Play the Video
Sara Witting Christensen Wen

ELCC 2026: Methylated Circulating Tumor DNA in Lung Cancer

/ Sara Witting Christensen Wen
ELCC26Lungecancer Play the Video
Alissa Cooper

ELCC 2026: Managing Pulmonary Neuroendocrine Tumors

/ Alissa Cooper
ELCC26Lungecancer Play the Video
Hent flere

Artikler

Danish and Nordic Lung Cancer Insights – January Update

/ Jan Andreasen / Amanda Feldballe Bernholm
lung cancer-highlightsLungecancer

Behandling af ALK-positiv NSCLC med lorlatinib i 1. linje giver markante kliniske fordele 

/ Jon Alexander Lykkegaard Andersen / Jan Andreasen
NSCLCLungecancer

Sustained Survival Benefit of Cemiplimab Plus Chemotherapy at 5 Years in Advanced NSCLC With PD-L1 ≥1%

/ Jan Andreasen
LungecancerImmunterapi

Lung Cancer Insights: What’s New in the Field – December Update

/ Jan Andreasen / Amanda Feldballe Bernholm
lung cancer-highlightsLungecancer

Danish and Nordic Lung Cancer Insights – December Update

/ Jan Andreasen / Amanda Feldballe Bernholm
lung cancer-highlightsLungecancer

Danish and Nordic Lung Cancer Insights – October Update

/ Jan Andreasen / Amanda Feldballe Bernholm
lung cancer-highlightsLungecancer
Back to top